Abbott announced the launch of the newly-approved NeuroSphere Virtual Clinic by which deep brain stimulation patients can have their devices programmed and reset remotely, from the comfort of their homes without having to travel to a specialist.
FDA approval brings remote programming for Abbott’s deep brain stimulation device
No Comments
Previous Post
Beckman Coulter seeks authorization for $4 antigen test
Next Post
Gilead’s cell therapy Yescarta awarded FDA approval for follicular lymphoma
Recent Posts
- Gilead’s cell therapy Yescarta awarded FDA approval for follicular lymphoma 08/03/2021
- FDA approval brings remote programming for Abbott’s deep brain stimulation device 08/03/2021
- Beckman Coulter seeks authorization for $4 antigen test 28/01/2021
- 3 tech-driven innovative patient engagement strategies transforming healthcare today 09/12/2020
- Lucira Covid-19 test is first to get FDA nod for home use 19/11/2020
Categories
- Coding (3)
- news (17)
- Photography (3)
- Social Marketing (3)
- uncategorized (1)
- WordPress (4)